{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T17:38:28Z","timestamp":1782236308968,"version":"3.54.5"},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.clinthera.2018.11.013","type":"journal-article","created":{"date-parts":[[2018,12,28]],"date-time":"2018-12-28T09:37:59Z","timestamp":1545989879000},"page":"118-127.e0","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Effects of Acute GLP-1 Infusion on Pulmonary and Systemic Hemodynamics in Patients With Heart Failure: A Pilot Study"],"prefix":"10.1016","volume":"41","author":[{"given":"Sophie J.","family":"Clarke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Pettit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel P.","family":"Giblett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna C.","family":"Kydd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolai J.W.","family":"Albrechtsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn F.","family":"Deacon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayan","family":"Parameshwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen P.","family":"Hoole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2018.11.013_bib1","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1093\/eurheartj\/ehn096","article-title":"The timing of development and subsequent clinical course of heart failure after a myocardial infarction","volume":"29","author":"Torabi","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.clinthera.2018.11.013_bib2","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1172\/JCI62874","article-title":"Myocardial ischemia-reperfusion injury: a neglected therapeutic target","volume":"123","author":"Hausenloy","year":"2013","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.clinthera.2018.11.013_bib3","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.jacc.2015.02.032","article-title":"Evolving therapies for myocardial ischemia\/reperfusion injury","volume":"65","author":"Ibanez","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.clinthera.2018.11.013_bib4","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2337\/diabetes.54.1.146","article-title":"Glucagon-like peptide 1 can directly protect the heart against ischemia\/reperfusion injury","volume":"54","author":"Bose","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.clinthera.2018.11.013_bib5","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jcin.2014.09.014","article-title":"Pre-treatment with glucagon-like peptide-1 protects against ischemic left ventricular dysfunction and stunning without a detected difference in myocardial substrate utilization","volume":"8","author":"McCormick","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.clinthera.2018.11.013_bib6","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12933-015-0259-3","article-title":"Glucagon-like peptide-1 protects against ischemic left ventricular dysfunction during hyperglycemia in patients with coronary artery disease and type 2 diabetes mellitus","volume":"14","author":"McCormick","year":"2015","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.clinthera.2018.11.013_bib7","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1161\/CIRCIMAGING.113.000785","article-title":"Chronic dipeptidyl peptidase-4 inhibition with sitagliptin is associated with sustained protection against ischemic left ventricular dysfunction in a pilot study of patients with type 2 diabetes mellitus and coronary artery disease","volume":"7","author":"McCormick","year":"2014","journal-title":"Circ Cardiovasc Imag"},{"key":"10.1016\/j.clinthera.2018.11.013_bib8","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/CIRCIMAGING.109.899377","article-title":"DPP-4 inhibition by sitagliptin improves the myocardial response to dobutamine stress and mitigates stunning in a pilot study of patients with coronary artery disease","volume":"3","author":"Read","year":"2010","journal-title":"Circ Cardiovasc Imag"},{"key":"10.1016\/j.clinthera.2018.11.013_bib9","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1136\/hrt.2010.219345","article-title":"Cardioprotection against ischaemia induced by dobutamine stress using glucagon-like peptide-1 in patients with coronary artery disease","volume":"98","author":"Read","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.clinthera.2018.11.013_bib10","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1161\/CIRCINTERVENTIONS.110.960476","article-title":"A\u00a0pilot study to assess whether glucagon-like peptide-1 protects the heart from ischemic dysfunction and attenuates stunning after coronary balloon occlusion in humans","volume":"4","author":"Read","year":"2011","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.clinthera.2018.11.013_bib11","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa1307684","article-title":"Raz I, for the SAVOR-TIMI 53 Steering Committee and Investigators. Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus","volume":"369","author":"Scirica","year":"2013","journal-title":"New Engl J Med"},{"key":"10.1016\/j.clinthera.2018.11.013_bib12","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1056\/NEJMoa1305889","article-title":"Alogliptin after acute coronary syndrome in patients with type 2 diabetes","volume":"369","author":"White","year":"2013","journal-title":"New Engl J Med"},{"key":"10.1016\/j.clinthera.2018.11.013_bib13","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12933-016-0416-3","article-title":"Glucagon-like peptide-1 derived cardioprotection does not utilize a KATP-channel dependent pathway: mechanistic insights from human supply and demand ischemia studies","volume":"15","author":"Giblett","year":"2016","journal-title":"Cardiovasc Diabetology"},{"key":"10.1016\/j.clinthera.2018.11.013_bib14","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/nm.3128","article-title":"GLP-1 receptor activation and EPAC2 link atrial natriuretic peptide secretion to control of blood pressure","volume":"19","author":"Kim","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.clinthera.2018.11.013_bib15","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0167-0115(01)00300-7","article-title":"Vasorelaxant effect of glucagon-like peptide-(7-36)amide and amylin on the pulmonary circulation of the rat","volume":"102","author":"Golpon","year":"2001","journal-title":"Regul Pept"},{"key":"10.1016\/j.clinthera.2018.11.013_bib16","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.abb.2008.08.001","article-title":"Glp-1 and related peptides cause concentration-dependent relaxation of rat aorta through a pathway involving Katp and Camp","volume":"478","author":"Green","year":"2008","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.clinthera.2018.11.013_bib17","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.regpep.2004.08.024","article-title":"Glucagon-like peptide-1 relaxes rat conduit arteries via an endothelium-independent mechanism","volume":"125","author":"Nystrom","year":"2005","journal-title":"Regul Pept"},{"key":"10.1016\/j.clinthera.2018.11.013_bib18","doi-asserted-by":"crossref","first-page":"E1209","DOI":"10.1152\/ajpendo.00237.2004","article-title":"Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease","volume":"287","author":"Nystrom","year":"2004","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.clinthera.2018.11.013_bib19","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1042\/CS20130708","article-title":"GLP-1 at physiological concentrations recruits skeletal and cardiac muscle microvasculature in healthy humans","volume":"127","author":"Subaran","year":"2014","journal-title":"Clin Sci"},{"key":"10.1016\/j.clinthera.2018.11.013_bib20","doi-asserted-by":"crossref","first-page":"e13073","DOI":"10.14814\/phy2.13073","article-title":"Glucagon-like peptide-1 elicits vasodilation in adipose tissue and skeletal muscle in healthy men","volume":"5","author":"Asmar","year":"2017","journal-title":"Physiol Rep"},{"key":"10.1016\/j.clinthera.2018.11.013_bib21","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.2337\/dc13-2618","article-title":"Simultaneous GLP-1 and insulin administration acutely enhances their vasodilatory, antiinflammatory, and antioxidant action in type 2 diabetes","volume":"37","author":"Ceriello","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinthera.2018.11.013_bib22","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1365-2125.2012.04214.x","article-title":"Investigation of the haemodynamic effects of exenatide in healthy male subjects","volume":"74","author":"Mendis","year":"2012","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2018.11.013_bib23","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/0002-9149(71)90436-X","article-title":"A\u00a0new technique for measurement of cardiac output by thermodilution in man","volume":"27","author":"Ganz","year":"1971","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.clinthera.2018.11.013_bib24","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1527-5299.2000.80139.x","article-title":"Comparative overview of cardiac output measurement methods: has impedance cardiography come of age?","volume":"6","author":"De Maria","year":"2000","journal-title":"Congest Heart Fail"},{"key":"10.1016\/j.clinthera.2018.11.013_bib25","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1213\/00000539-199402000-00010","article-title":"Calculated versus measured oxygen consumption during aortic surgery: reliability of the Fick method","volume":"78","author":"Pestana","year":"1994","journal-title":"Anesth Analgesia"},{"key":"10.1016\/j.clinthera.2018.11.013_bib26","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJM198710223171717","article-title":"Simplified calculation of body-surface area","volume":"317","author":"Mosteller","year":"1987","journal-title":"New Engl J Med"},{"key":"10.1016\/j.clinthera.2018.11.013_bib27","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1161\/CIRCULATIONAHA.107.739938","article-title":"Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways","volume":"117","author":"Ban","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2018.11.013_bib28","doi-asserted-by":"crossref","first-page":"888","DOI":"10.2337\/db11-1073","article-title":"Glucagon-like peptide 1 recruits microvasculature and increases glucose use in muscle via a nitric oxide-dependent mechanism","volume":"61","author":"Chai","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.clinthera.2018.11.013_bib29","first-page":"L374","article-title":"GLP-1 stimulates secretion of macromolecules from airways and relaxes pulmonary artery","volume":"265","author":"Richter","year":"1993","journal-title":"Am J Physiol"},{"key":"10.1016\/j.clinthera.2018.11.013_bib30","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000084277","article-title":"Effect of glucagon-like peptide-1(7-36) and exendin-4 on the vascular reactivity in streptozotocin\/nicotinamide-induced diabetic rats","volume":"74","author":"Ozyazgan","year":"2005","journal-title":"Pharmacology"},{"key":"10.1016\/j.clinthera.2018.11.013_bib31","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1124\/jpet.105.093104","article-title":"Mesenteric vasoconstriction and hindquarters vasodilatation accompany the pressor actions of exendin-4 in conscious rats","volume":"316","author":"Gardiner","year":"2006","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.clinthera.2018.11.013_bib32","first-page":"E784","article-title":"Neural contribution to the effect of glucagon-like peptide-1-(7-36) amide on arterial blood pressure in rats","volume":"277","author":"Barragan","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1016\/j.clinthera.2018.11.013_bib33","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/dom.13128","article-title":"Effects of glucagon-like peptide-1 (GLP-1) receptor agonists on cardiovascular risk factors: a narrative review of head-to-head comparisons","volume":"20","author":"Dalsgaard","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.clinthera.2018.11.013_bib34","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1177\/1479164114547358","article-title":"The effect of liraglutide on endothelial function in patients with type 2 diabetes","volume":"11","author":"Nandy","year":"2014","journal-title":"Diab Vasc Dis Res"},{"key":"10.1016\/j.clinthera.2018.11.013_bib35","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/dom.12651","article-title":"Short-term effects of liraglutide on kidney function and vasoactive hormones in type 2 diabetes: a randomized clinical trial","volume":"18","author":"Skov","year":"2016","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.clinthera.2018.11.013_bib36","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1530\/EC-13-0087","article-title":"Glucagon-like peptide-1: effect on pro-atrial natriuretic peptide in healthy males","volume":"3","author":"Skov","year":"2014","journal-title":"Endocr Connections"},{"key":"10.1016\/j.clinthera.2018.11.013_bib37","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2337\/dc14-1958","article-title":"Liraglutide promotes natriuresis but does not increase circulating levels of atrial natriuretic peptide in hypertensive subjects with type 2 diabetes","volume":"38","author":"Lovshin","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinthera.2018.11.013_bib38","doi-asserted-by":"crossref","first-page":"H1287","DOI":"10.1152\/ajpheart.00835.2014","article-title":"An interaction between glucagon-like peptide-1 and adenosine contributes to cardioprotection of a dipeptidyl peptidase 4 inhibitor from myocardial ischemia-reperfusion injury","volume":"308","author":"Ihara","year":"2015","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.clinthera.2018.11.013_bib39","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.2337\/db13-1440","article-title":"Identification and characterization of Glp-1 receptor-expressing cells using a new transgenic mouse model","volume":"63","author":"Richards","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.clinthera.2018.11.013_bib40","article-title":"Measurement of cardiac output in the cath lab: how accurate is it?","volume":"22","author":"Kern","year":"2014","journal-title":"Cath Lab Dig"},{"key":"10.1016\/j.clinthera.2018.11.013_bib41","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1161\/CIRCULATIONAHA.113.003334","article-title":"Inaccuracy of estimated resting oxygen uptake in the clinical setting","volume":"129","author":"Narang","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2018.11.013_bib42","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1001\/jamacardio.2017.2945","article-title":"Thermodilution vs estimated Fick cardiac output measurement in clinical practice: an analysis of mortality from the veterans affairs clinical assessment, reporting, and tracking (VA CART) program and Vanderbilt University","volume":"2","author":"Opotowsky","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.clinthera.2018.11.013_bib43","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.010321","article-title":"GLP-1 is a coronary artery vasodilator in humans","author":"Clarke","year":"2018","journal-title":"J\u00a0Am Heart Assoc"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291818305939?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291818305939?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,14]],"date-time":"2019-01-14T22:51:52Z","timestamp":1547506312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291818305939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0149291818305939"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2018.11.013","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of Acute GLP-1 Infusion on Pulmonary and Systemic Hemodynamics in Patients With Heart Failure: A Pilot Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2018.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}